Novo Nordisk A/S NOVO-B.CO Stock
Novo Nordisk A/S Price Chart
Novo Nordisk A/S NOVO-B.CO Financial and Trading Overview
| Novo Nordisk A/S stock price | 866.1 DKK |
| Previous Close | 664.2 DKK |
| Open | 658.2 DKK |
| Bid | 663.3 DKK x 0 |
| Ask | 663.8 DKK x 0 |
| Day's Range | 657.4 - 668.5 DKK |
| 52 Week Range | 448.25 - 742.2 DKK |
| Volume | 5.5M DKK |
| Avg. Volume | 2.86M DKK |
| Market Cap | 2.96T DKK |
| Beta (5Y Monthly) | 0.194 |
| PE Ratio (TTM) | 39.677227 |
| EPS (TTM) | 18.66 DKK |
| Forward Dividend & Yield | 7.08 (1.06%) |
| Ex-Dividend Date | August 18, 2023 |
| 1y Target Est | 716.92 DKK |
NOVO-B.CO Valuation Measures
| Enterprise Value | 2.95T DKK |
| Trailing P/E | 39.677227 |
| Forward P/E | 29.51534 |
| PEG Ratio (5 yr expected) | 1.18 |
| Price/Sales (ttm) | 13.800658 |
| Price/Book (mrq) | 31.958017 |
| Enterprise Value/Revenue | 13.757 |
| Enterprise Value/EBITDA | 29.476 |
Trading Information
Novo Nordisk A/S Stock Price History
| Beta (5Y Monthly) | 0.194 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 742.2 DKK |
| 52 Week Low | 448.25 DKK |
| 50-Day Moving Average | 687.81 DKK |
| 200-Day Moving Average | 603.65 DKK |
NOVO-B.CO Share Statistics
| Avg. Volume (3 month) | 2.86M DKK |
| Avg. Daily Volume (10-Days) | 2.81M DKK |
| Shares Outstanding | 3.38B |
| Float | 3.31B |
| Short Ratio | N/A |
| % Held by Insiders | 5.97% |
| % Held by Institutions | 38.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 7.075 |
| Trailing Annual Dividend Yield | 1.06% |
| 5 Year Average Dividend Yield | 173.00% |
| Payout Ratio | 0.42310002 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 35.11% |
| Operating Margin (ttm) | 45.82% |
| Gross Margin | 84.14% |
| EBITDA Margin | 46.67% |
Management Effectiveness
| Return on Assets (ttm) | 21.57% |
| Return on Equity (ttm) | 88.77% |
Income Statement
| Revenue (ttm) | 214.49B DKK |
| Revenue Per Share (ttm) | 47.73 DKK |
| Quarterly Revenue Growth (yoy) | 28.89% |
| Gross Profit (ttm) | 148.51B DKK |
| EBITDA | 100.11B DKK |
| Net Income Avi to Common (ttm) | 75.31B DKK |
| Diluted EPS (ttm) | 16.73 |
| Quarterly Earnings Growth (yoy) | 56.00% |
Balance Sheet
| Total Cash (mrq) | 47.59B DKK |
| Total Cash Per Share (mrq) | 10.63 DKK |
| Total Debt (mrq) | 26.54B DKK |
| Total Debt/Equity (mrq) | 28.54 DKK |
| Current Ratio (mrq) | 0.824 |
| Book Value Per Share (mrq) | 20.771 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 106.46B DKK |
| Levered Free Cash Flow (ttm) | 63.8B DKK |
Profile of Novo Nordisk A/S
| Country | Denmark |
| State | N/A |
| City | Bagsvaerd |
| Address | Novo Alle 1 |
| ZIP | 2880 |
| Phone | 45 44 44 88 88 |
| Website | https://www.novonordisk.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 61412 |
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novo Nordisk A/S Stock
What is a current NOVO-B.CO stock price?
Novo Nordisk A/S NOVO-B.CO stock price today per share is 866.1 DKK.
How to purchase Novo Nordisk A/S stock?
You can buy NOVO-B.CO shares on the Copenhagen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novo Nordisk A/S?
The stock symbol or ticker of Novo Nordisk A/S is NOVO-B.CO.
Which industry does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S industry is Biotechnology.
How many shares does Novo Nordisk A/S have in circulation?
The max supply of Novo Nordisk A/S shares is 4.53B.
What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?
Novo Nordisk A/S PE Ratio is 47.15970000 now.
What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?
Novo Nordisk A/S EPS is 18.66 DKK over the trailing 12 months.
Which sector does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S sector is Healthcare.
Novo Nordisk A/S NOVO-B.CO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ OMX Nordic 120 NOMXN120 | 1615.32 EUR 1765.76 USD |
+0.22
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_GI OMXCCAPGI | 2771.14 DKK 406.31 USD |
-0.58
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Pharmaceuticals CX201030PI | 10605.7 DKK 1555.02 USD |
+1.02
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Benchmark_GI OMXCBGI | 4260.2 DKK 624.64 USD |
+0.54
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Benchmark Cap_GI OMXCBCAPGI | 2664.2 DKK 390.63 USD |
-0.4
|
— — | — — | — — | — - | — — |
| OMX Copenhagen 20 CAP OMXC20CAP | 1835.4 DKK 269.11 USD |
<0.01
|
— — | 1835.4 DKK 269.11 USD | 1835.4 DKK 269.11 USD | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| OMX_Nordic_Large_Cap_EUR_GI OMXNLCEURGI | 424.25 EUR 463.76 USD |
-0.11
|
— — | — — | — — | — - | — — |
| Nasdaq CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
| OMX Nordic 40 OMXN40 | 2739.03 EUR 2994.12 USD |
+0.2
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Nordic 120 SEK Net I NOMXN120SEKNI | 2582.04 SEK 252.04 USD |
+0.74
|
— — | — — | — — | — - | — — |
| OMX_Copenhagen_Large_Cap_PI OMXCLCPI | 561.78 DKK 82.37 USD |
+0.4
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_SEK_GI OMXNLCSEKGI | 529.96 SEK 51.73 USD |
+0.39
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Nordic 120 Gross Ind NOMXN120GI | 2495.84 EUR 2728.29 USD |
+0.25
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_PI OMXCCAPPI | 1455.94 DKK 213.47 USD |
-0.6
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}